Clinical Predictors and Risk Factors for Relapsing Clostridium difficile Infection
Authors:
- Jose CadenaJCJose Cadena
- George R. ThompsonGTGeorge R. Thompson
- Jan E. PattersonJPJan E. Patterson
- Kelly EchevarriaKEKelly Echevarria
- Brandy NakashimaBNBrandy Nakashima
- Eric M. MortensenEMEric M. Mortensen
- Aaron OwensAOAaron Owens
- 1 April 2010
- journal article
- research article
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 339 (4) , 350-355
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Prospective Derivation and Validation of a Clinical Prediction Rule for Recurrent Clostridium difficile InfectionGastroenterology, 2009
- Is over-use of proton pump inhibitors fuelling the current epidemic of Clostridium difficile-associated diarrhoea?Journal of Hospital Infection, 2008
- Clostridium difficile: Emergence of Hypervirulence and Fluoroquinolone ResistanceInfection, 2007
- Narrative Review: The New Epidemic of Clostridium difficile–Associated Enteric DiseaseAnnals of Internal Medicine, 2006
- Clostridium difficileInfection in Patients Discharged from US Short-stay Hospitals, 1996–20031Emerging Infectious Diseases, 2006
- An Epidemic, Toxin Gene–Variant Strain ofClostridium difficileNew England Journal of Medicine, 2005
- Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, CanadaClinical Infectious Diseases, 2005
- Fluoroquinolone Use andClostridium difficile–associated DiarrheaEmerging Infectious Diseases, 2003
- Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoeaThe Lancet, 2001
- Recurrent Clostridium Difficile Disease: Epidemiology and Clinical CharacteristicsInfection Control & Hospital Epidemiology, 1999